Published in Br J Cancer on January 13, 2015
Exosomes: small vesicles with big roles in hepatocellular carcinoma. Oncotarget (2016) 1.43
Exosomes in cancer: small particle, big player. J Hematol Oncol (2015) 1.29
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer (2015) 1.13
Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology. BMC Clin Pathol (2015) 1.02
Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res (2016) 0.86
Non-Coding RNAs in Primary Liver Cancer. Front Med (Lausanne) (2015) 0.85
Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers. Int J Mol Sci (2016) 0.83
Exosomes in liver pathology. J Hepatol (2016) 0.83
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Clin Med (2016) 0.81
MicroRNAs in extracellular vesicles: potential cancer biomarkers. J Hum Genet (2016) 0.81
Exosomes as potent regulators of HCC malignancy and potential bio-tools in clinical application. Int J Clin Exp Med (2015) 0.78
Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease. Int J Mol Sci (2016) 0.77
Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets. J Clin Med (2015) 0.77
Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Oncotarget (2016) 0.76
Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers. Expert Rev Mol Diagn (2016) 0.76
Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer. Langenbecks Arch Surg (2016) 0.76
Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth. Cell Death Dis (2017) 0.75
A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity. BMC Med Genomics (2016) 0.75
Extracellular miRNAs as biomarkers in cancer. Food Chem Toxicol (2016) 0.75
Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma. Biomed Res Int (2017) 0.75
Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients. J Clin Med (2015) 0.75
Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer. Oncol Lett (2017) 0.75
Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells. J Zhejiang Univ Sci B (2017) 0.75
Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria. World J Hepatol (2016) 0.75
Specific circulating microRNA signature of bicuspid aortic valve disease. J Transl Med (2017) 0.75
MicroRNA profiling in kidney disease: Plasma versus plasma-derived exosomes. Gene (2017) 0.75
Enlarged selection criteria for hepatocellular cancer: is the upper limit needed? Transl Gastroenterol Hepatol (2017) 0.75
Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets. Nat Rev Gastroenterol Hepatol (2017) 0.75
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 11.46
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
Exosomes--vesicular carriers for intercellular communication. Curr Opin Cell Biol (2009) 6.96
The Hox genes and their roles in oncogenesis. Nat Rev Cancer (2010) 3.97
Updated treatment approach to hepatocellular carcinoma. J Gastroenterol (2005) 3.43
ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res (2011) 3.28
Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci (2013) 1.81
Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One (2011) 1.78
Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci (2012) 1.76
Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation (2009) 1.69
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology (2011) 1.68
Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One (2012) 1.67
MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res (2011) 1.66
Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. Cancer Biomark (2007) 1.65
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal (2014) 1.62
Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol (2011) 1.62
Exosomal miRNAs: Biological Properties and Therapeutic Potential. Front Genet (2012) 1.60
Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open (2012) 1.50
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50
Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem (2013) 1.37
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers (2009) 1.35
Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS One (2012) 1.28
Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Mol Oncol (2012) 1.28
The roles of extracellular vesicles in cancer biology: toward the development of novel cancer biomarkers. Proteomics (2014) 1.10
Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumour Biol (2013) 1.08
Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res (2005) 1.07
Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int (2014) 1.01
Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation. Am J Transplant (2011) 1.00
Clinical aspects of hepatocellular carcinoma in Japan. Intern Med (2006) 0.87
MicroRNAs as biomarkers for hepatocellular carcinoma: a diagnostic meta-analysis. Clin Lab (2013) 0.85
A paradigm shift for extracellular vesicles as small RNA carriers: from cellular waste elimination to therapeutic applications. Drug Deliv Transl Res (2014) 0.84
Tumor-Derived Exosomes Contain microRNAs with Immunological Function: Implications for a Novel Immunosuppression Mechanism. Microrna (2014) 0.83
Prognostic significance of preoperative imaging in recipients of living donor liver transplantation for hepatocellular carcinoma. Transplantation (2011) 0.78
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer (2015) 1.13
Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer. Br J Cancer (2015) 0.84
Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation. Clin Radiol (2014) 0.77